PL366916A1 - Zastosowanie pochodnych pirydoindolonu do wytwarzania leków - Google Patents

Zastosowanie pochodnych pirydoindolonu do wytwarzania leków

Info

Publication number: PL366916A1
Authority: PL; Poland
Prior art keywords: preparing anticancer; anticancer medicines; pyridoindolone derivatives; pyridoindolone; derivatives
Prior art date: 2001-04-27

Application number

PL02366916A

Other languages

English (en)

Inventor

Bernard Bourrie

Pierre Casellas

Jean-Marie Derocq

Original Assignee

Sanofi-Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-27

Filing date

2002-04-26

Publication date

2005-02-07

2002-04-26 Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis

2005-02-07 Publication of PL366916A1 publication Critical patent/PL366916A1/pl

Links

230000001093 anti-cancer Effects 0.000 title 1
229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1
YNHGMRWHXVMPEN-UHFFFAOYSA-N pyrrolo[2,3-f]quinolin-2-one Chemical class C1=CC=C2C3=NC(=O)C=C3C=CC2=N1 YNHGMRWHXVMPEN-UHFFFAOYSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL02366916A 2001-04-27 2002-04-26 Zastosowanie pochodnych pirydoindolonu do wytwarzania leków PL366916A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0105843A FR2823975B1 (fr)	2001-04-27	2001-04-27	Nouvelle utilisation de pyridoindolone

Publications (1)

Publication Number	Publication Date
PL366916A1 true PL366916A1 (pl)	2005-02-07

Family

ID=8862882

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL02366910A PL366910A1 (pl)	2001-04-27	2002-04-26	Środki farmaceutyczne oparte na pochodnych pirydoindolonu
PL02366916A PL366916A1 (pl)	2001-04-27	2002-04-26	Zastosowanie pochodnych pirydoindolonu do wytwarzania leków

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL02366910A PL366910A1 (pl)	2001-04-27	2002-04-26	Środki farmaceutyczne oparte na pochodnych pirydoindolonu

Country Status (33)

Country	Link
US (3)	US7524857B2 (pl)
EP (2)	EP1385513B1 (pl)
JP (2)	JP2004531538A (pl)
KR (1)	KR100847413B1 (pl)
CN (2)	CN1505511A (pl)
AR (1)	AR034313A1 (pl)
AT (2)	ATE338548T1 (pl)
BG (2)	BG108260A (pl)
BR (1)	BR0209138A (pl)
CA (2)	CA2443012C (pl)
CY (1)	CY1105813T1 (pl)
CZ (2)	CZ295224B6 (pl)
DE (2)	DE60214533T2 (pl)
DK (2)	DK1385512T3 (pl)
EA (1)	EA005930B1 (pl)
EE (2)	EE200300465A (pl)
ES (2)	ES2271264T3 (pl)
FR (1)	FR2823975B1 (pl)
HU (2)	HUP0400745A2 (pl)
IL (4)	IL158312A0 (pl)
IS (1)	IS2441B (pl)
MX (1)	MXPA03009639A (pl)
NO (2)	NO20034785L (pl)
NZ (1)	NZ528671A (pl)
PL (2)	PL366910A1 (pl)
PT (2)	PT1385513E (pl)
RS (2)	RS50791B (pl)
RU (1)	RU2292888C9 (pl)
SK (2)	SK13252003A3 (pl)
TW (1)	TWI252104B (pl)
UA (1)	UA74876C2 (pl)
WO (2)	WO2002087575A1 (pl)
ZA (1)	ZA200307785B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2823975B1 (fr) *	2001-04-27	2003-05-30	Sanofi Synthelabo	Nouvelle utilisation de pyridoindolone
US7456193B2 (en) *	2002-10-23	2008-11-25	Sanofi-Aventis	Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2846329B1 (fr) *	2002-10-23	2004-12-03	Sanofi Synthelabo	Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
FR2869316B1 (fr) *	2004-04-21	2006-06-02	Sanofi Synthelabo	Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2892416B1 (fr) *	2005-10-20	2008-06-27	Sanofi Aventis Sa	Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1268772A (en) *	1968-03-15	1972-03-29	Glaxo Lab Ltd	NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
US4263304A (en) *	1978-06-05	1981-04-21	Sumitomo Chemical Company, Limited	7 H-indolo[2,3-c]isoquinolines
SU833971A1 (ru) *	1979-07-10	1981-05-30	Ленинградский Химико-Фармацевтическийинститут	Способ получени 3-фенил-2-оксо- - КАРбОлиНОВ
SU833972A1 (ru)	1979-10-26	1981-05-30	Институт Физико-Органической Химиии Углехимии Ah Украинской Ccp	Имидазо(4,5-с)пиридиний иодиды вКАчЕСТВЕ пРОМЕжуТОчНыХ пРОдуКТОВ дл СиНТЕзА фуНгицидОВ
FR2595701B1 (fr) *	1986-03-17	1988-07-01	Sanofi Sa	Derives du pyrido-indole, leur application a titre de medicaments et les compositions les renfermant
US5035252A (en) *	1990-12-14	1991-07-30	Mondre Steven J	Nicotine-containing dental floss
EP0581388A1 (en) *	1992-07-30	1994-02-02	Glaxo Group Limited	Pyridoindolone Methansulphonate as 5HT and 5HT3 receptor antagonists
JPH10501686A (ja) *	1994-04-13	1998-02-17	ザロックフェラーユニヴァーシティ	神経系の細胞へのｄｎａのａａｖ仲介送達
DE19502753A1 (de) *	1995-01-23	1996-07-25	Schering Ag	Neue 9H-Pyrido[3,4-b]indol-Derivate
US6486177B2 (en) *	1995-12-04	2002-11-26	Celgene Corporation	Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
DE19624659A1 (de) *	1996-06-20	1998-01-08	Klinge Co Chem Pharm Fab	Neue Pyridylalken- und Pyridylalkinsäureamide
FR2765581B1 (fr) *	1997-07-03	1999-08-06	Synthelabo	Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique
FR2765582B1 (fr) *	1997-07-03	1999-08-06	Synthelabo	Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
EP1068205A1 (en) *	1998-04-02	2001-01-17	Neurogen Corporation	Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino 2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino 4,5-b]indole derivatives: crf1 specific ligands
IT1313592B1 (it)	1999-08-03	2002-09-09	Novuspharma Spa	Derivati di 1h-pirido 3,4-b indol-1-one.
US20020156016A1 (en) *	2001-03-30	2002-10-24	Gerald Minuk	Control of cell growth by altering cell membrane potentials
FR2823975B1 (fr) *	2001-04-27	2003-05-30	Sanofi Synthelabo	Nouvelle utilisation de pyridoindolone
FR2846330B1 (fr)	2002-10-23	2004-12-03	Sanofi Synthelabo	Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique
FR2846329B1 (fr)	2002-10-23	2004-12-03	Sanofi Synthelabo	Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
US6958347B2 (en)	2002-12-18	2005-10-25	Pfizer Inc.	Aminophenanthridinone and aminophenanthridine as NPY-5 antagonists
FR2869316B1 (fr)	2004-04-21	2006-06-02	Sanofi Synthelabo	Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2892416B1 (fr)	2005-10-20	2008-06-27	Sanofi Aventis Sa	Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

2001
- 2001-04-27 FR FR0105843A patent/FR2823975B1/fr not_active Expired - Fee Related
2002
- 2002-04-26 US US10/476,321 patent/US7524857B2/en not_active Expired - Lifetime
- 2002-04-26 HU HU0400745A patent/HUP0400745A2/hu unknown
- 2002-04-26 AR ARP020101521A patent/AR034313A1/es unknown
- 2002-04-26 RS YUP-839/03A patent/RS50791B/sr unknown
- 2002-04-26 EE EEP200300465A patent/EE200300465A/xx unknown
- 2002-04-26 IL IL15831202A patent/IL158312A0/xx unknown
- 2002-04-26 MX MXPA03009639A patent/MXPA03009639A/es active IP Right Grant
- 2002-04-26 US US10/476,322 patent/US6967203B2/en not_active Expired - Lifetime
- 2002-04-26 PT PT02735502T patent/PT1385513E/pt unknown
- 2002-04-26 CA CA002443012A patent/CA2443012C/fr not_active Expired - Fee Related
- 2002-04-26 EP EP02735502A patent/EP1385513B1/fr not_active Expired - Lifetime
- 2002-04-26 PT PT02732841T patent/PT1385512E/pt unknown
- 2002-04-26 HU HU0400744A patent/HUP0400744A2/hu unknown
- 2002-04-26 UA UA2003109248A patent/UA74876C2/uk unknown
- 2002-04-26 RS YUP-834/03A patent/RS50790B/sr unknown
- 2002-04-26 JP JP2002584920A patent/JP2004531538A/ja active Pending
- 2002-04-26 DK DK02732841T patent/DK1385512T3/da active
- 2002-04-26 WO PCT/FR2002/001450 patent/WO2002087575A1/fr not_active Ceased
- 2002-04-26 ES ES02735502T patent/ES2271264T3/es not_active Expired - Lifetime
- 2002-04-26 IL IL15826602A patent/IL158266A0/xx unknown
- 2002-04-26 CZ CZ20032909A patent/CZ295224B6/cs not_active IP Right Cessation
- 2002-04-26 EP EP02732841A patent/EP1385512B1/fr not_active Expired - Lifetime
- 2002-04-26 CA CA002444334A patent/CA2444334A1/fr not_active Abandoned
- 2002-04-26 SK SK1325-2003A patent/SK13252003A3/sk unknown
- 2002-04-26 JP JP2002584919A patent/JP2004528343A/ja active Pending
- 2002-04-26 AT AT02735502T patent/ATE338548T1/de not_active IP Right Cessation
- 2002-04-26 WO PCT/FR2002/001449 patent/WO2002087574A2/fr not_active Ceased
- 2002-04-26 DE DE60214533T patent/DE60214533T2/de not_active Expired - Lifetime
- 2002-04-26 CZ CZ20032910A patent/CZ299465B6/cs not_active IP Right Cessation
- 2002-04-26 EE EEP200300466A patent/EE200300466A/xx unknown
- 2002-04-26 CN CNA028089596A patent/CN1505511A/zh active Pending
- 2002-04-26 ES ES02732841T patent/ES2254683T3/es not_active Expired - Lifetime
- 2002-04-26 CN CNB028088980A patent/CN1240382C/zh not_active Expired - Fee Related
- 2002-04-26 PL PL02366910A patent/PL366910A1/pl unknown
- 2002-04-26 EA EA200301062A patent/EA005930B1/ru not_active IP Right Cessation
- 2002-04-26 DE DE60208365T patent/DE60208365T2/de not_active Expired - Lifetime
- 2002-04-26 RU RU2003130376/15A patent/RU2292888C9/ru active
- 2002-04-26 TW TW091108716A patent/TWI252104B/zh not_active IP Right Cessation
- 2002-04-26 AT AT02732841T patent/ATE314070T1/de not_active IP Right Cessation
- 2002-04-26 KR KR1020037013925A patent/KR100847413B1/ko not_active Expired - Fee Related
- 2002-04-26 BR BR0209138-0A patent/BR0209138A/pt not_active IP Right Cessation
- 2002-04-26 SK SK1324-2003A patent/SK13242003A3/sk unknown
- 2002-04-26 NZ NZ528671A patent/NZ528671A/en unknown
- 2002-04-26 DK DK02735502T patent/DK1385513T3/da active
- 2002-04-26 PL PL02366916A patent/PL366916A1/pl not_active IP Right Cessation
2003
- 2003-10-02 IL IL158266A patent/IL158266A/en not_active IP Right Cessation
- 2003-10-06 ZA ZA200307785A patent/ZA200307785B/en unknown
- 2003-10-08 IL IL158312A patent/IL158312A/en not_active IP Right Cessation
- 2003-10-09 IS IS6984A patent/IS2441B/is unknown
- 2003-10-13 BG BG108260A patent/BG108260A/bg unknown
- 2003-10-13 BG BG108261A patent/BG108261A/bg unknown
- 2003-10-24 NO NO20034785A patent/NO20034785L/no not_active Application Discontinuation
- 2003-10-24 NO NO20034787A patent/NO20034787L/no not_active Application Discontinuation
2005
- 2005-08-15 US US11/204,275 patent/US7160895B2/en not_active Expired - Lifetime
2006
- 2006-11-30 CY CY20061101725T patent/CY1105813T1/el unknown

Also Published As

Publication number	Publication date
JP2004528343A (ja)	2004-09-16
PT1385513E (pt)	2007-01-31
NO20034787D0 (no)	2003-10-24
ES2254683T3 (es)	2006-06-16
NZ528671A (en)	2004-06-25
SK13242003A3 (sk)	2004-03-02
PL366910A1 (pl)	2005-02-07
DE60214533T2 (de)	2007-06-21
US20040122036A1 (en)	2004-06-24
KR100847413B1 (ko)	2008-07-18
DE60214533D1 (de)	2006-10-19
RS50791B (sr)	2010-08-31
BR0209138A (pt)	2004-06-08
DE60208365T2 (de)	2006-09-07
CN1240382C (zh)	2006-02-08
CY1105813T1 (el)	2011-02-02
TWI252104B (en)	2006-04-01
WO2002087574A2 (fr)	2002-11-07
KR20040015138A (ko)	2004-02-18
ES2271264T3 (es)	2007-04-16
EP1385513B1 (fr)	2006-09-06
US7524857B2 (en)	2009-04-28
WO2002087575A1 (fr)	2002-11-07
IS6984A (is)	2003-10-09
RS50790B (sr)	2010-08-31
DE60208365D1 (de)	2006-02-02
IL158266A0 (en)	2004-05-12
DK1385513T3 (da)	2007-01-15
WO2002087574A3 (fr)	2003-02-13
US20050272760A1 (en)	2005-12-08
ATE314070T1 (de)	2006-01-15
SK13252003A3 (sk)	2004-03-02
MXPA03009639A (es)	2004-06-30
AR034313A1 (es)	2004-02-18
CZ299465B6 (cs)	2008-08-06
NO20034785L (no)	2003-12-23
RU2292888C9 (ru)	2007-06-20
CA2443012A1 (en)	2002-11-07
CN1505510A (zh)	2004-06-16
HUP0400744A2 (hu)	2004-06-28
CZ20032910A3 (en)	2004-07-14
HK1059895A1 (en)	2004-07-23
CZ20032909A3 (en)	2004-06-16
EA005930B1 (ru)	2005-08-25
CN1505511A (zh)	2004-06-16
ATE338548T1 (de)	2006-09-15
BG108261A (bg)	2004-12-30
CA2444334A1 (fr)	2002-11-07
DK1385512T3 (da)	2006-05-22
IL158312A0 (en)	2004-05-12
CA2443012C (fr)	2009-07-28
US7160895B2 (en)	2007-01-09
PT1385512E (pt)	2006-05-31
US6967203B2 (en)	2005-11-22
IL158266A (en)	2009-09-01
HK1060066A1 (en)	2004-07-30
EE200300466A (et)	2003-12-15
RU2003130376A (ru)	2005-04-10
NO20034787L (no)	2003-12-23
IL158312A (en)	2009-09-01
UA74876C2 (en)	2006-02-15
US20040122027A1 (en)	2004-06-24
EA200301062A1 (ru)	2004-04-29
YU83403A (sh)	2006-08-17
EP1385512A2 (fr)	2004-02-04
FR2823975B1 (fr)	2003-05-30
EP1385512B1 (fr)	2005-12-28
BG108260A (bg)	2004-12-30
EP1385513A1 (fr)	2004-02-04
EE200300465A (et)	2003-12-15
ZA200307785B (en)	2004-10-06
RU2292888C2 (ru)	2007-02-10
HUP0400745A2 (hu)	2004-08-30
JP2004531538A (ja)	2004-10-14
YU83903A (sh)	2006-08-17
IS2441B (is)	2008-11-15
FR2823975A1 (fr)	2002-10-31
NO20034785D0 (no)	2003-10-24
CZ295224B6 (cs)	2005-06-15

Legal Events

Date	Code	Title	Description
2011-02-28	VOID	Decisions declaring the decisions on the grant of the patent lapsed

Publication	Publication Date	Title
HUP0401642A3 (en)	2008-05-28	Use of staurosporine derivatives for the preparation of pharmaceutical compositions
HUP0700039A2 (en)	2007-05-02	Use of cannabinoid drugs for the preparation of medicines for decreasing cell proliferation
AU2001235691A1 (en)	2001-08-27	Use of paullone derivatives for making medicines
IL159725A0 (en)	2004-06-20	Pharmaceutical compositions containing benzimidazole derivatives
HUP0400314A3 (en)	2006-02-28	Pharmaceutical combinations for the treatment of cancer
HUP0400200A3 (en)	2008-03-28	Pharmaceutical formulation for the efficient administration of apomorphine, 6ar-(-)-n-propyl-norapomorphine and their derivatives and pro-drugs thereof
IL156988A0 (en)	2004-02-08	Pharmaceutical compositions containing epothilone derivatives
HUP0401747A3 (en)	2005-06-28	Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
IL157128A0 (en)	2004-02-08	Pharmaceutical compositions containing epothilone derivatives
AU2177001A (en)	2001-06-04	Use of indirubine derivatives for making medicines
HUP0401600A3 (en)	2008-05-28	Process for the preparation of 14-hydroxymorphine derivatives
HUP0303443A3 (en)	2012-09-28	Process for the preparation of imidazole derivatives
GB0127832D0 (en)	2002-01-09	Method for the preparation of pharmaceutical nanosuspensions
PT1446107E (pt)	2014-09-12	Composições orais de libertação controlada compreendendo um composto de vitamina d e veículo ceroso
IL162385A0 (en)	2005-11-20	Process for the preparation of echinocandin derivatives
HUP0202016A3 (en)	2005-02-28	Taxane derivatives, the use of them for producing anti-cancer medicaments, these medicaments and processes for preparation of these derivatives
IL158360A0 (en)	2004-05-12	Process for the preparation of 7-substituted 3-alkyl-3h-isobenzofuran-1-one derivatives
HUP0500958A2 (en)	2006-01-30	2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them, therapeutic use thereof and pharmaceutical compositions containing them
IL158312A (en)	2009-09-01	Use of pyridoindolone derivatives for preparing anticancer medicines
IL162510A0 (en)	2005-11-20	Pharmaceutical suspension for oral administration
EP1176150A4 (en)	2003-04-23	A METHOD FOR PRODUCING TRIFLUOROTHYMIDINE DERIVATIVES
HUP0200913A3 (en)	2004-11-29	Isoindoindololone derivatives process for their preparation and pharmaceutical compositions containing them
SI1245565T1 (en)	2003-12-31	Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them
AU2002304551B2 (en)	2007-04-19	Use of pyridoindolone derivatives for preparing anticancer medicines
HUP0200993A3 (en)	2003-05-28	Thio-oxindole derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them